Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate -252.63% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
- OPERATING CASH FLOW(Y) Lowest at USD -4.34 MM
- RAW MATERIAL COST(Y) Grown by 3,595.83% (YoY)
- DEBTORS TURNOVER RATIO(HY) Lowest at 9.18 times
Risky - Negative EBITDA
Below par performance in long term as well as near term
Stock DNA
Specialty Chemicals
USD 33 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.74
-32.02%
0.32
Total Returns (Price + Dividend) 
Vivakor, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
Is Vivakor, Inc. technically bullish or bearish?
As of 5 September 2025, the technical trend for Vivakor, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish with a weak strength indicated by the weekly MACD and Bollinger Bands both showing bearish signals, alongside bearish moving averages. The Dow Theory also reflects a mildly bearish position on the weekly basis. In terms of performance, Vivakor has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -50.42% compared to the S&P 500's 12.22%, and a one-year return of -57.70% versus the S&P 500's 17.14%....
Read MoreIs Vivakor, Inc. overvalued or undervalued?
As of 21 November 2022, Vivakor, Inc. has moved from a grade of "does not qualify" to "risky," indicating a significant downgrade in its valuation outlook. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 0.34 and an EV to Sales ratio of 0.97, which suggest that the market may not be pricing in the inherent risks associated with its financial performance. Additionally, the EV to EBITDA ratio stands at an alarming -53.69, further underscoring the company's struggles. In comparison to its peers, Vivakor's valuation ratios are concerning; for instance, Codexis, Inc. has a PE ratio of -3.5684 and an EV to EBITDA of -3.9373, while Comstock, Inc. shows a PE of -3.1557 and an EV to EBITDA of -3.6324, indicating that Vivakor is not only underperforming but also carries a higher risk profile. The company's stock has significantly lagged behind the S&P 500, w...
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 3 Schemes (0.97%)
Held by 3 Foreign Institutions (0.08%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is -21.98% vs -10.55% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is -66.67% vs 61.34% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 51.43% vs 111.03% in Dec 2023
YoY Growth in year ended Dec 2024 is -144.44% vs 46.53% in Dec 2023






